The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. For the above reasons, Medindia cannot be held ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

(Reuters) - Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline. Vectura said the court ...

Novartis data at ERS 2014 show once-daily Ultibro® Breezhaler® is superior in reducing COPD flare ups compared to Seretide® Once-daily Ultibro® Breezhaler® reduced exacerbations (flare ups) by 31% ...

Glenmark Pharmaceuticals today said it has received three observations from the US health regulator for its Pithampur, Indore plant. (Source: website) Glenmark Pharmaceuticals has entered into an ...

Basel, April 30, 2014 - Novartis today announced positive first results from the Phase III head-to-head LANTERN study, which showed the superiority of once-daily ...

(Alliance News) - Vectura Group PLC on Friday said the English High Court dismissed a case against Sandoz Ltd's generic version of GlaxsmithKline PLC's Seretide Accuhaler. The case was bought against ...

"Glenmark Pharmaceuticals Europe today has entered into a strategic development & licensing agreement with Celon Pharma SA to develop and market a generic version of GlaxoSmithKline's Seretide ...

LONDON & BRISBANE, Calif.--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has approved a label update for the use of ...

Glenmark Pharmaceuticals Europe Ltd has entered into a strategic development and licensing agreement with Celon Pharma SA to develop and market a generic version of GSK's Seretide Accuhaler product - ...